Peregrine Capital Management LLC Purchases 17,478 Shares of HealthEquity, Inc. $HQY

Peregrine Capital Management LLC boosted its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 16.1% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 126,231 shares of the company’s stock after buying an additional 17,478 shares during the period. Peregrine Capital Management LLC’s holdings in HealthEquity were worth $10,549,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of HQY. Acumen Wealth Advisors LLC acquired a new position in shares of HealthEquity in the 4th quarter valued at approximately $27,000. Caitong International Asset Management Co. Ltd boosted its position in shares of HealthEquity by 1,723.5% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after acquiring an additional 293 shares in the last quarter. Aster Capital Management DIFC Ltd acquired a new stake in shares of HealthEquity during the 4th quarter worth approximately $28,000. Torren Management LLC bought a new position in HealthEquity in the fourth quarter valued at approximately $40,000. Finally, Northwestern Mutual Wealth Management Co. increased its stake in HealthEquity by 190.4% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 604 shares of the company’s stock valued at $55,000 after acquiring an additional 396 shares during the last quarter. 99.55% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, Director Gayle Furgurson Wellborn sold 2,439 shares of the business’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $219,510.00. Following the sale, the director directly owned 19,733 shares in the company, valued at approximately $1,775,970. The trade was a 11.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of the company’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total value of $675,000.00. Following the completion of the transaction, the executive vice president directly owned 91,141 shares of the company’s stock, valued at $8,202,690. This represents a 7.60% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 13,081 shares of company stock valued at $1,193,000 in the last 90 days. Corporate insiders own 1.60% of the company’s stock.

HealthEquity Stock Performance

NASDAQ HQY opened at $90.32 on Wednesday. The firm’s fifty day moving average price is $85.45 and its two-hundred day moving average price is $84.64. The stock has a market cap of $7.55 billion, a PE ratio of 33.83, a PEG ratio of 1.48 and a beta of 0.21. HealthEquity, Inc. has a fifty-two week low of $72.76 and a fifty-two week high of $105.96. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The company had revenue of $354.64 million during the quarter, compared to the consensus estimate of $352.02 million. The firm’s revenue for the quarter was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, equities analysts expect that HealthEquity, Inc. will post 3.92 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on HQY shares. Deutsche Bank Aktiengesellschaft upped their target price on HealthEquity from $120.00 to $128.00 and gave the stock a “buy” rating in a research note on Thursday, March 19th. KeyCorp reissued an “overweight” rating on shares of HealthEquity in a report on Tuesday, May 26th. Wall Street Zen upgraded HealthEquity from a “hold” rating to a “buy” rating in a research report on Saturday, June 6th. Weiss Ratings raised HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, June 5th. Finally, Wells Fargo & Company set a $111.00 target price on HealthEquity in a research report on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $110.57.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.